NCT04244552 2023-12-29
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies
Atreca, Inc.
Phase 1 Terminated
Atreca, Inc.
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
Santa Maria Biotherapeutics